Global Retinal Disease Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4916355
- 89 Pages
- March 2022
- Medical Devices
The United States Retinal Disease Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Retinal Disease Therapeutics market, reaching US$ million by the year 2028. As for the Europe Retinal Disease Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Retinal Disease Therapeutics players cover Merck, Novartis, Allergan, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Retinal Disease Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Retail Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck
Novartis
Allergan
Roche
Regeneron
Santen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Retinal Disease Therapeutics Market Size 2017-2028
2.1.2 Retinal Disease Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Retinal Disease Therapeutics Segment by Type
2.2.1 Macular Degeneration
2.2.2 Diabetic Macular Edema
2.2.3 Diabetic Retinopathy
2.2.4 Retinal Vein Occlusion
2.3 Retinal Disease Therapeutics Market Size by Type
2.3.1 Retinal Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Retinal Disease Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Retinal Disease Therapeutics Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Retinal Disease Therapeutics Market Size by Application
2.5.1 Retinal Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Retinal Disease Therapeutics Market Size Market Share by Application (2017-2022)
3 Retinal Disease Therapeutics Market Size by Player
3.1 Retinal Disease Therapeutics Market Size Market Share by Players
3.1.1 Global Retinal Disease Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Retinal Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Retinal Disease Therapeutics by Regions
4.1 Retinal Disease Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Retinal Disease Therapeutics Market Size Growth (2017-2022)
4.3 APAC Retinal Disease Therapeutics Market Size Growth (2017-2022)
4.4 Europe Retinal Disease Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Retinal Disease Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Retinal Disease Therapeutics Market Size by Country (2017-2022)
5.2 Americas Retinal Disease Therapeutics Market Size by Type (2017-2022)
5.3 Americas Retinal Disease Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Retinal Disease Therapeutics Market Size by Region (2017-2022)
6.2 APAC Retinal Disease Therapeutics Market Size by Type (2017-2022)
6.3 APAC Retinal Disease Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Retinal Disease Therapeutics by Country (2017-2022)
7.2 Europe Retinal Disease Therapeutics Market Size by Type (2017-2022)
7.3 Europe Retinal Disease Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Retinal Disease Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Retinal Disease Therapeutics Market Forecast
10.1 Global Retinal Disease Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Retinal Disease Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Retinal Disease Therapeutics Forecast
10.1.3 APAC Retinal Disease Therapeutics Forecast
10.1.4 Europe Retinal Disease Therapeutics Forecast
10.1.5 Middle East & Africa Retinal Disease Therapeutics Forecast
10.2 Americas Retinal Disease Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Retinal Disease Therapeutics Market Forecast
10.2.2 Canada Retinal Disease Therapeutics Market Forecast
10.2.3 Mexico Retinal Disease Therapeutics Market Forecast
10.2.4 Brazil Retinal Disease Therapeutics Market Forecast
10.3 APAC Retinal Disease Therapeutics Forecast by Region (2023-2028)
10.3.1 China Retinal Disease Therapeutics Market Forecast
10.3.2 Japan Retinal Disease Therapeutics Market Forecast
10.3.3 Korea Retinal Disease Therapeutics Market Forecast
10.3.4 Southeast Asia Retinal Disease Therapeutics Market Forecast
10.3.5 India Retinal Disease Therapeutics Market Forecast
10.3.6 Australia Retinal Disease Therapeutics Market Forecast
10.4 Europe Retinal Disease Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Retinal Disease Therapeutics Market Forecast
10.4.2 France Retinal Disease Therapeutics Market Forecast
10.4.3 UK Retinal Disease Therapeutics Market Forecast
10.4.4 Italy Retinal Disease Therapeutics Market Forecast
10.4.5 Russia Retinal Disease Therapeutics Market Forecast
10.5 Middle East & Africa Retinal Disease Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Retinal Disease Therapeutics Market Forecast
10.5.2 South Africa Retinal Disease Therapeutics Market Forecast
10.5.3 Israel Retinal Disease Therapeutics Market Forecast
10.5.4 Turkey Retinal Disease Therapeutics Market Forecast
10.5.5 GCC Countries Retinal Disease Therapeutics Market Forecast
10.6 Global Retinal Disease Therapeutics Forecast by Type (2023-2028)
10.7 Global Retinal Disease Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Retinal Disease Therapeutics Product Offered
11.1.3 Merck Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Merck Main Business Overview
11.1.5 Merck Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Retinal Disease Therapeutics Product Offered
11.2.3 Novartis Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Allergan
11.3.1 Allergan Company Information
11.3.2 Allergan Retinal Disease Therapeutics Product Offered
11.3.3 Allergan Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Allergan Main Business Overview
11.3.5 Allergan Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Retinal Disease Therapeutics Product Offered
11.4.3 Roche Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Regeneron
11.5.1 Regeneron Company Information
11.5.2 Regeneron Retinal Disease Therapeutics Product Offered
11.5.3 Regeneron Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Regeneron Main Business Overview
11.5.5 Regeneron Latest Developments
11.6 Santen
11.6.1 Santen Company Information
11.6.2 Santen Retinal Disease Therapeutics Product Offered
11.6.3 Santen Retinal Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Santen Main Business Overview
11.6.5 Santen Latest Developments
12 Research Findings and Conclusion
Table 1. Retinal Disease Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Macular Degeneration
Table 3. Major Players of Diabetic Macular Edema
Table 4. Major Players of Diabetic Retinopathy
Table 5. Major Players of Retinal Vein Occlusion
Table 6. Retinal Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Retinal Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Retinal Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 9. Retinal Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Retinal Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Retinal Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 12. Global Retinal Disease Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Retinal Disease Therapeutics Revenue Market Share by Player (2020-2022)
Table 14. Retinal Disease Therapeutics Key Players Head office and Products Offered
Table 15. Retinal Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Retinal Disease Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Retinal Disease Therapeutics Market Size Market Share by Regions (2017-2022)
Table 20. Americas Retinal Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Retinal Disease Therapeutics Market Size Market Share by Country (2017-2022)
Table 22. Americas Retinal Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Retinal Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 24. Americas Retinal Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Retinal Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 26. APAC Retinal Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Retinal Disease Therapeutics Market Size Market Share by Region (2017-2022)
Table 28. APAC Retinal Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Retinal Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 30. APAC Retinal Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Retinal Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 32. Europe Retinal Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Retinal Disease Therapeutics Market Size Market Share by Country (2017-2022)
Table 34. Europe Retinal Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Retinal Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 36. Europe Retinal Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Retinal Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Retinal Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Retinal Disease Therapeutics
Table 45. Key Market Challenges & Risks of Retinal Disease Therapeutics
Table 46. Key Industry Trends of Retinal Disease Therapeutics
Table 47. Global Retinal Disease Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Retinal Disease Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Retinal Disease Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Retinal Disease Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Retinal Disease Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Retinal Disease Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 53. Merck Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 54. Merck Retinal Disease Therapeutics Product Offered
Table 55. Merck Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Merck Main Business
Table 57. Merck Latest Developments
Table 58. Novartis Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 59. Novartis Retinal Disease Therapeutics Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Novartis Latest Developments
Table 63. Allergan Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 64. Allergan Retinal Disease Therapeutics Product Offered
Table 65. Allergan Main Business
Table 66. Allergan Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Allergan Latest Developments
Table 68. Roche Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 69. Roche Retinal Disease Therapeutics Product Offered
Table 70. Roche Main Business
Table 71. Roche Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Roche Latest Developments
Table 73. Regeneron Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 74. Regeneron Retinal Disease Therapeutics Product Offered
Table 75. Regeneron Main Business
Table 76. Regeneron Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Regeneron Latest Developments
Table 78. Santen Details, Company Type, Retinal Disease Therapeutics Area Served and Its Competitors
Table 79. Santen Retinal Disease Therapeutics Product Offered
Table 80. Santen Main Business
Table 81. Santen Retinal Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Santen Latest Developments
List of Figures
Figure 1. Retinal Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Retinal Disease Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Retinal Disease Therapeutics Market Size Market Share by Type in 2021
Figure 7. Retinal Disease Therapeutics in Hospital Pharmacy
Figure 8. Global Retinal Disease Therapeutics Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Retinal Disease Therapeutics in Retail Pharmacy
Figure 10. Global Retinal Disease Therapeutics Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Retinal Disease Therapeutics in Others
Figure 12. Global Retinal Disease Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Retinal Disease Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Retinal Disease Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Retinal Disease Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Retinal Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Retinal Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Retinal Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Retinal Disease Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Retinal Disease Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Retinal Disease Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Retinal Disease Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Retinal Disease Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Retinal Disease Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Retinal Disease Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Retinal Disease Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Retinal Disease Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Retinal Disease Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Retinal Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Retinal Disease Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
